JP2023551734A5 - - Google Patents
Info
- Publication number
- JP2023551734A5 JP2023551734A5 JP2023533830A JP2023533830A JP2023551734A5 JP 2023551734 A5 JP2023551734 A5 JP 2023551734A5 JP 2023533830 A JP2023533830 A JP 2023533830A JP 2023533830 A JP2023533830 A JP 2023533830A JP 2023551734 A5 JP2023551734 A5 JP 2023551734A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- amino acid
- antibody
- hvr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063121629P | 2020-12-04 | 2020-12-04 | |
| US63/121,629 | 2020-12-04 | ||
| PCT/US2021/061755 WO2022120137A1 (en) | 2020-12-04 | 2021-12-03 | Compositions and methods for treating ocular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023551734A JP2023551734A (ja) | 2023-12-12 |
| JP2023551734A5 true JP2023551734A5 (cg-RX-API-DMAC7.html) | 2024-12-10 |
Family
ID=81853584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023533830A Pending JP2023551734A (ja) | 2020-12-04 | 2021-12-03 | 眼の疾患を治療するための組成物及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240059765A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4255485A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023551734A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230117192A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116782940A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021391800A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3200976A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2023001596A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL303289A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023006591A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022120137A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3019240T3 (da) | 2013-07-09 | 2024-06-03 | Annexon Inc | Anti-komplementfaktor C1Q antistoffer og anvendelser deraf |
| EP3380518B1 (en) | 2015-11-24 | 2026-03-25 | Annexon, Inc. | Anti-complement factor c1q fab fragments and uses thereof |
| US12486322B2 (en) | 2021-12-13 | 2025-12-02 | Annexon, Inc. | Anti-complement factor C1q antibodies with single binding arms and uses thereof |
| AU2023262202A1 (en) * | 2022-04-29 | 2024-10-24 | Annexon, Inc. | Compositions and methods for treating ocular diseases. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3019240T3 (da) * | 2013-07-09 | 2024-06-03 | Annexon Inc | Anti-komplementfaktor C1Q antistoffer og anvendelser deraf |
| EP3380518B1 (en) * | 2015-11-24 | 2026-03-25 | Annexon, Inc. | Anti-complement factor c1q fab fragments and uses thereof |
-
2021
- 2021-12-03 CN CN202180090142.XA patent/CN116782940A/zh active Pending
- 2021-12-03 IL IL303289A patent/IL303289A/en unknown
- 2021-12-03 EP EP21901508.8A patent/EP4255485A4/en active Pending
- 2021-12-03 WO PCT/US2021/061755 patent/WO2022120137A1/en not_active Ceased
- 2021-12-03 US US18/265,380 patent/US20240059765A1/en active Pending
- 2021-12-03 MX MX2023006591A patent/MX2023006591A/es unknown
- 2021-12-03 JP JP2023533830A patent/JP2023551734A/ja active Pending
- 2021-12-03 AU AU2021391800A patent/AU2021391800A1/en active Pending
- 2021-12-03 KR KR1020237022463A patent/KR20230117192A/ko active Pending
- 2021-12-03 CA CA3200976A patent/CA3200976A1/en active Pending
-
2023
- 2023-06-02 CL CL2023001596A patent/CL2023001596A1/es unknown